Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fahima Nekka

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Child and Adolescent Psychopharmacology|February 5, 2019
A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentSara Soufsaf, Philippe Robaey, Guillaume Bonnefois, et al.
Clinical and Translational Science|February 16, 2022
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulationsAbdullah Aljutayli, Daniel J G Thirion, Guillaume Bonnefois, et al.
Chaos (Woodbury, N.Y.)|March 3, 2021
Dynamical systems analysis as an additional tool to inform treatment outcomes: The case study of a quantitative systems pharmacology model of immuno-oncologyAymen Balti, Didier Zugaj, Frédérique Fenneteau, et al.
Plos One|July 18, 2018
Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAARTSteven Sanche, Thibault Mesplède, Nancy L Sheehan, et al.
Biopharmaceutics & Drug Disposition|April 8, 2015
Impact of sampling time deviations on the prediction of the area under the curve using regression limited sampling strategiesSarem Sarem, Fahima Nekka, Iman Saad Ahmed, et al.
Chaos (Woodbury, N.Y.)|October 2, 2020
Nonlinear pharmacodynamics of levodopa through Parkinson's disease progressionFlorence Véronneau-Veilleux, Mauro Ursino, Philippe Robaey, et al.
Theoretical Biology & Medical Modelling|January 17, 2009
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determinationFrédérique Fenneteau, Jacques Turgeon, Lucie Couture, et al.
Bulletin of Mathematical Biology|July 4, 2002
Spatial effects in modeling pharmacokinetics of rapid action drugsPatrick Lafrance, Vincent Lemaire, France Varin, et al.
Expert Review of Clinical Pharmacology|November 5, 2016
Pharmacometrics-based decision tools facilitate mHealth implementationFahima Nekka, Chantal Csajka, Mélanie Wilbaux, et al.
British Journal of Clinical Pharmacology|December 31, 2016
Modelling the dose-response relationship: the fair share of pharmacokinetic and pharmacodynamic informationMario González-Sales, Fahima Nekka, Mario Tanguay, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Child and Adolescent Psychopharmacology|February 5, 2019
A Quantitative Comparison Approach for Methylphenidate Drug Regimens in Attention-Deficit/Hyperactivity Disorder TreatmentSara Soufsaf, Philippe Robaey, Guillaume Bonnefois, et al.
Clinical and Translational Science|February 16, 2022
Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulationsAbdullah Aljutayli, Daniel J G Thirion, Guillaume Bonnefois, et al.
Chaos (Woodbury, N.Y.)|March 3, 2021
Dynamical systems analysis as an additional tool to inform treatment outcomes: The case study of a quantitative systems pharmacology model of immuno-oncologyAymen Balti, Didier Zugaj, Frédérique Fenneteau, et al.
Plos One|July 18, 2018
Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAARTSteven Sanche, Thibault Mesplède, Nancy L Sheehan, et al.
Biopharmaceutics & Drug Disposition|April 8, 2015
Impact of sampling time deviations on the prediction of the area under the curve using regression limited sampling strategiesSarem Sarem, Fahima Nekka, Iman Saad Ahmed, et al.
Chaos (Woodbury, N.Y.)|October 2, 2020
Nonlinear pharmacodynamics of levodopa through Parkinson's disease progressionFlorence Véronneau-Veilleux, Mauro Ursino, Philippe Robaey, et al.
Theoretical Biology & Medical Modelling|January 17, 2009
Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determinationFrédérique Fenneteau, Jacques Turgeon, Lucie Couture, et al.
Bulletin of Mathematical Biology|July 4, 2002
Spatial effects in modeling pharmacokinetics of rapid action drugsPatrick Lafrance, Vincent Lemaire, France Varin, et al.
Expert Review of Clinical Pharmacology|November 5, 2016
Pharmacometrics-based decision tools facilitate mHealth implementationFahima Nekka, Chantal Csajka, Mélanie Wilbaux, et al.
British Journal of Clinical Pharmacology|December 31, 2016
Modelling the dose-response relationship: the fair share of pharmacokinetic and pharmacodynamic informationMario González-Sales, Fahima Nekka, Mario Tanguay, et al.
Pageof 6